BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1531466)

  • 1. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
    Falsetti L; De Fusco D; Eleftheriou G; Rosina B
    Gynecol Endocrinol; 1997 Aug; 11(4):251-7. PubMed ID: 9272421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
    Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism.
    Falsetti L; Gambera A
    Fertil Steril; 1999 Jul; 72(1):41-6. PubMed ID: 10428146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.
    Moghetti P; Castello R; Negri C; Tosi F; Magnani CM; Fontanarosa MC; Armanini D; Muggeo M
    Fertil Steril; 1995 Sep; 64(3):511-7. PubMed ID: 7641903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.
    Pucci E; Genazzani AD; Monzani F; Lippi F; Angelini F; Gargani M; Barletta D; Luisi M; Genazzani AR
    Gynecol Endocrinol; 1995 Sep; 9(3):221-8. PubMed ID: 8540292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
    Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
    Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism.
    Couzinet B; Pholsena M; Young J; Schaison G
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):157-62. PubMed ID: 8370128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
    Müderris II; Bayram F
    J Endocrinol Invest; 1999 Mar; 22(3):165-8. PubMed ID: 10219882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of finasteride versus flutamide in the treatment of hirsutism.
    Falsetti L; Gambera A; Legrenzi L; Iacobello C; Bugari G
    Eur J Endocrinol; 1999 Oct; 141(4):361-7. PubMed ID: 10526249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of flutamide in the management of hirsutism.
    Marugo M; Bernasconi D; Meozzi M; Del Monte P; Zino V; Primarolo P; Badaracco B
    J Endocrinol Invest; 1994 Mar; 17(3):195-9. PubMed ID: 8051342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
    Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
    Müderris II; Bayram F; Güven M
    Fertil Steril; 2000 May; 73(5):984-7. PubMed ID: 10785225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
    Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
    Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-receptor blockade does not impair bone mineral density in adolescent females.
    Bertelloni S; Baroncelli GI; Sorrentino MC; Costa S; Battini R; Saggese G
    Calcif Tissue Int; 1997 Jul; 61(1):1-5. PubMed ID: 9192502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.